These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6286547)

  • 1. Experimental radiotherapy with WR-2721 and misonidazole.
    Rojas A; Stewart FA; Denekamp J
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):527-30. PubMed ID: 6286547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1982 May; 45(5):684-93. PubMed ID: 6282299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioprotection combined with hypoxic sensitization during radiotherapy of a solid murine tumor.
    Mendiondo OA; Grigsby PW; Beach JL
    Radiology; 1983 Jul; 148(1):291-3. PubMed ID: 6304811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitizers and protectors in clinical oncology.
    Phillips TL
    Semin Oncol; 1981 Mar; 8(1):65-82. PubMed ID: 6264627
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
    McNally NJ
    Br J Cancer; 1982 Oct; 46(4):670-4. PubMed ID: 6291565
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of WR 2721 on the efficacy of radiotherapy and chemotherapy of murine tumors.
    Clement JJ; Johnson RK
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):539-42. PubMed ID: 6286550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the radiation response of the mouse kidney by misonidazole and WR-2721.
    Williams MV; Denekamp J
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1731-6. PubMed ID: 6315650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS; Nelson NJ; Mahler P; Anderson K; Krohn KA; Menard T
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined radiosensitization and radioprotection for oral cavity tumors: study with an oral cavity tumor model.
    Grigsby P; Maruyama Y
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):557-9. PubMed ID: 6286553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of X ray dose levels on normal tissue radioprotection by WR-2721.
    Rojas A; Denekamp J
    Int J Radiat Oncol Biol Phys; 1984 Dec; 10(12):2351-6. PubMed ID: 6096318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of stromal radiosensitivity by misonidazole and WR-2721.
    Begg AC; Terry NH
    Br J Radiol; 1983 Aug; 56(668):565-70. PubMed ID: 6307455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole.
    Grigsby P; Maruyama Y
    Br J Radiol; 1981 Nov; 54(647):969-72. PubMed ID: 6272925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the radioprotective drugs MEA, DMSO, and WR-2721 on tumor control and skin tolerance in the rat.
    Moulder JE; Lo PS; Fischer JJ
    Cancer Treat Rep; 1977 Aug; 61(5):825-33. PubMed ID: 196752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tumor type, size, and endpoint on tumor radioprotection by WR-2721.
    Milas L; Hunter N; Ito H; Peters LJ
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):41-8. PubMed ID: 6321411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionation studies with WR-2721: normal tissues and tumour.
    Rojas A; Stewart FA; Soranson JA; Smith KA; Denekamp J
    Radiother Oncol; 1986 May; 6(1):51-60. PubMed ID: 3012656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitizers and protectors in radiotherapy.
    Brown JM
    Cancer; 1985 May; 55(9 Suppl):2222-8. PubMed ID: 2983876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy testing of WR-2721 in Great Britain everything is black and white at the gray lab.
    Yuhas JM
    Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):595-8. PubMed ID: 6303993
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
    Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
    Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.